Evaluation of in vitro activity of double β-lactam therapy and relationship with PBP activity in Escherichia coli isolates

被引：0
|
作者：
Suich, J. [1 ,2 ]
van der Woude, M. [2 ]
Wearmouth, D. [1 ]
Burns, P. [1 ]
Barlow, G. [1 ,2 ]
机构：
[1] Hull Univ Teaching Hosp NHS Trust, Kingston Upon Hull, N Humberside, England
[2] Univ York, York, N Yorkshire, England
来源：
JAC-ANTIMICROBIAL RESISTANCE | 2022年 / 4卷 / SUPPL 2期
关键词：
D O I：
10.1093/jacamr/dlac053.011
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P11
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Evaluation of in vitro activity of double β-lactam 'therapy' in Escherichia coli: what is the association between 'synergy' and in vitro susceptibility?
    Suich, J.
    Van Der Woude, M.
    Wearmouth, D.
    Burns, P.
    Barlow, G.
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (SUPP_2):
  • [2] Evaluation of in vitro activity of double β-lactam 'therapy' in ESBL plus /CPE plus Escherichia coli-what is the association between 'synergy' and in vitro susceptibility?
    Suich, J.
    Van der Woude, M.
    Wearmouth, D.
    Burns, P.
    Barlow, G.
    JAC-ANTIMICROBIAL RESISTANCE, 2024, 6
  • [3] In vitro activity of β-lactam and non-β-lactam antibiotics in extended-spectrum β-lactamase-producing clinical isolates of Escherichia coli
    Puerto, AS
    Fernández, JG
    del Castillo, JDL
    Pino, MJS
    Angulo, GP
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 54 (02) : 135 - 139
  • [4] Evaluation of In Vitro Activity of Fosfomycin and Other Antimicrobial Agents against Urinary Escherichia coli Isolates
    Uzun, Aslihan
    Gulen, Dumrul
    Tanriverdi, Yeliz
    Kaya, Ayse Demet
    KLIMIK JOURNAL, 2012, 25 (02) : 77 - 80
  • [5] In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli
    Karlowsky, James A.
    Adam, Heather J.
    Baxter, Melanie R.
    Denisuik, Andrew J.
    Lagace-Wiens, Philippe R. S.
    Walkty, Andrew J.
    Puttagunta, Sailaja
    Dunne, Michael W.
    Zhanel, George G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (01)
  • [6] In vitro activity of cefditoren against clinical isolates of Escherichia coli from a Korean hospital
    Ko, Kwan Soo
    Suh, Ji Yoeun
    Lee, Mi Young
    Lee, Nam Yong
    Peck, Kyong Ran
    Kwon, Ki Tae
    Jung, Dong Sik
    Song, Jae-Hoon
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (03) : 283 - 285
  • [7] Comparative in-vitro activity of cefaclor against urinary tract isolates of Escherichia coli
    Webster, CA
    Curran, R
    Towner, KJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) : 59 - 66
  • [8] Evaluation of in vitro antibacterial activity of some disinfectants on Escherichia coli serotypes
    El-Naggar, MYM
    Akeila, MA
    Turk, HA
    El-Ebady, AA
    Sahaly, MZ
    JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY, 2001, 47 (02): : 63 - 73
  • [9] In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli
    M. Tärnberg
    Å. Östholm-Balkhed
    H.-J. Monstein
    A. Hällgren
    H. Hanberger
    L. E. Nilsson
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 981 - 987
  • [10] Impact of defined cell envelope mutations in Escherichia coli on the in vitro antibacterial activity of avibactam/β-lactam combinations
    McLeod, Sarah M.
    Patey, Sara A.
    Huband, Michael D.
    Nichols, Wright W.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (04) : 437 - 442
12345